Recovery Guide Intervention for Recurrent Psychiatric Hospitalization
This study has been completed.
Sponsor:
Yale University
Collaborators:
Connecticut State, Department of Mental Health and Addiction Services
Eli Lilly and Company
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00400166
First received: November 15, 2006
Last updated: June 10, 2009
Last verified: June 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience high rates of inpatient hospitalizations.
| Condition | Intervention |
|---|---|
|
Schizophrenia Schizoaffective Disorder Bipolar Disorder Psychotic Depression |
Behavioral: Recovery Mentor |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Recovery Guide Intervention for Recurrent Psychiatric Hospitalization |
Resource links provided by NLM:
MedlinePlus related topics:
Bipolar Disorder
Depression
Mental Disorders
Psychotic Disorders
Schizophrenia
U.S. FDA Resources
Further study details as provided by Yale University:
Primary Outcome Measures:
- Number of hospitalizations [ Time Frame: 9 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Sense of community [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
- Motivation for change [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
- Social functioning [ Time Frame: Baseline, 3 abd 9 months ] [ Designated as safety issue: No ]
- Hope [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
- Self-determination [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
- Functional status [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
- Treatment relationship [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
| Enrollment: | 71 |
| Study Start Date: | December 2006 |
| Study Completion Date: | May 2009 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Recovery Mentor: peer-based supportive care
|
Behavioral: Recovery Mentor
Provided Recovery Mentor services
|
|
No Intervention: 0
No Recovery Mentor, services as usual
|
Detailed Description:
The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The Recovery Guide model is just such a model. Beyond theoretical frameworks, the effectiveness of Recovery Guides has not been well studied. It is the intent of this study to conduct a randomized trial examining the effects of Recovery Guides on community tenure and integration. Furthermore, it is the intent of this study to to establish fidelity criteria.
Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 18 years of age or older
- Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
- A history of two or more prior admissions within the past 18 months
- Proficient in the use of the English language
- A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features
Exclusion Criteria:
- Inability to give signed, written consent
- Primary DSM-IV diagnosis of substance abuse/dependence
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00400166
Locations
| United States, Connecticut | |
| Yale-New Haven Psychiatric Hospital | |
| New Haven, Connecticut, United States, 06519 | |
Sponsors and Collaborators
Yale University
Connecticut State, Department of Mental Health and Addiction Services
Eli Lilly and Company
Investigators
| Principal Investigator: | William H Sledge, MD | Yale University |
More Information
Additional Information:
No publications provided
| Responsible Party: | William H. Sledge, M.D.; Director, Yale Psychiatric Hospital; Chair, Yale Department of Psychiatry; George D & Esther S Gross Professor of Psychiatry, Yale University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00400166 History of Changes |
| Other Study ID Numbers: | 0607001641 |
| Study First Received: | November 15, 2006 |
| Last Updated: | June 10, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Yale University:
|
Peer support Psychiatric disability Mutual support Psychiatric Rehabilitation |
Additional relevant MeSH terms:
|
Bipolar Disorder Depression Depressive Disorder Mental Disorders Psychotic Disorders Schizophrenia |
Depressive Disorder, Major Affective Disorders, Psychotic Mood Disorders Behavioral Symptoms Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on May 23, 2013